Key Market Segments:
By Type
-
Polymerase Chain Reaction (PCR) Tests
-
Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
-
Ligase Chain Reaction (LCR) Tests
By Application
-
Infectious Disease Testing
-
COVID-19 Testing
-
Mosquito-Borne Disease Testing
-
Influenza Testing
-
Sexually Transmitted Infections Testing
-
Hepatitis Testing
-
Tuberculosis Testing
-
Others
-
-
Oncology Testing
-
Genetic & Mitochondrial Disease Testing
-
Others
By End-use
-
Hospitals
-
Central And Reference Laboratories
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America is the dominant region in the Nucleic Acid Amplification Testing market.
The high cost associated with molecular diagnostic tests and instruments, makes them less accessible in resource-limited settings.
The nucleic acid amplification testing (NAAT) market is fueled mainly by advances in molecular diagnostics and the growing infectious disease burden globally.
By 2032, the Nucleic Acid Amplification Testing market is expected to reach USD 20.62 billion, up from USD 7.36 billion in 2023.
The Nucleic Acid Amplification Testing market is projected to grow at a CAGR of 12.16% during the forecast period.